[1] Schlapbach L J,Watson R S,Sorce L R,et al.International consensus criteria for pediatric sepsis and septic shock[J].JAMA,2024,331(8):665-674. [2] 任艳艳,虞志新,杨宏锋,等.脓毒症并发肝损伤患者血清GP73和miR-122a与miR-125b水平及其预测价值[J].中华医院感染学杂志,2024,34(03):366-370. [3] 尹艳萍,牟菲,尹艳丽,等.脓毒症诱导肝损伤的致病机制和中药及其有效成分治疗研究进展[J].中国中药杂志,2024,49(04):884-893. [4] 戴昱婕,胡婷婷,孙捷睿,等.吡喹酮对脂多糖诱导脓毒症小鼠急性肝损伤的保护作用[J].中国病原生物学杂志,2024,19(10):1123-1128. [5] Cai J,Tang D,Hao X,et al. Mesenchymal stem cell-derived exosome alleviates sepsis- associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis[J]. Front Immunol, 2023, 14: 1157793. [6] Rasooli A,Fatemi F,Hajihosseini R,et al.Synergistic effects of deuterium depleted water and Mentha longifolia L.essential oils on sepsis-induced liver injuries through regulation of cyclooxygenase-2[J].Pharm Biol,2019,57(1):125-132. [7] 周拓,丁锋,赵登峰.血必净减轻脓毒症肝细胞损伤的作用及机制研究[J].中国临床药理学杂志,2024,40(16):2349-2353. [8] 王富春,张万洁,李子怡,等.查尔森共病指数对慢加急性肝衰竭患者预后的评估价值[J].临床肝胆病杂志,2023,39(05):1098-1104. [9] 徐大洲,张树贤,王坤,等.血清簇集蛋白、1-磷酸鞘氨醇水平对脓毒症急性肝损伤患者的预后价值[J].临床肝胆病杂志,2023,39(12):2867-2872. [10] 甘宇婧,史如鹏,吴丹瑛,等.老年脓毒症患者早期炎症因子水平及预后的相关性分析[J].南京医科大学学报(自然科学版),2023,43(09):1208-1215. [11] Cui N, Zhang H, Chen Z, et,al. Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases[J]. J Int Med Res,2019,47(4):1573-1579. [12] 陆剑萍,覃家茂,韦昭华.复方甘草酸苷联合恩替卡韦治疗HBV相关ACLF疗效分析[J].中南医学科学杂志,2023,51(01):61-64. [13] 崔雪曼,杨赞儒,付海燕,等.NLR和HBD-1与M30对乙型肝炎病毒感染相关慢加急性肝衰竭患者人工肝治疗短期预后的预测价值[J].中华医院感染学杂志,2024,34(11):1621-1625. [14] Xu X, Hou Z, Xu Y, et,al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients[J]. Clin Res Hepatol Gastroenterol,2021,45(2):101482. [15] van der Poll T, Shankar-Hari M, Wiersinga W J. The immunology of sepsis[J]. Immunity,2021,54(11):2450-2464. [16] 石庆玲,郭卫东,徐振兴.不同病原体类型脓毒症患者的临床特征及对预后的影响因素[J].中国病原生物学杂志,2024,19(11):1317-1321+1326. [17] 马勇,高伟波,朱继红.细菌性肝脓肿患者发生血小板减少影响因素研究[J].中国全科医学,2023,26(17):2120-2124. [18] Assinger A,Schrottmaier W C,Salzmann M,et al. Platelets in sepsis:an update on experimental models and clinical data[J]. Front Immunol,2019,10:1687. [19] Takahashi K, Nagai S, Collins K M, et,al. Factors associated with low graft regeneration in the early phase after living donor liver transplantation[J]. Clin Transplant,2019,33(10):e13690. [20] 丁伟超,陈娟,叶英,等.血必净注射液治疗脓毒症相关急性呼吸窘迫综合征肺热血瘀证患者的临床疗效[J].中草药,2024,55(19):6645-6654. |